| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 203 |
| 1 | INFLIXIMAB | 202 |
| 2 | ETANERCEPT | 199 |
| 3 | METHOTREXATE SODIUM | 197 |
| 4 | SULFASALAZINE | 196 |
| 5 | METHOTREXATE | 193 |
| 6 | LEFLUNOMIDE | 192 |
| 7 | ABATACEPT | 189 |
| 8 | TOCILIZUMAB | 188 |
| 9 | RITUXIMAB | 179 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DIMENHYDRINATE | 113 | 0.0158 |
| 1 | TETRACAINE HYDROCHLORIDE | 1 | 0.0112 |
| 2 | FEBUXOSTAT | 125 | 0.0112 |
| 3 | GOLD | 43 | 0.0108 |
| 4 | DICLOFENAC POTASSIUM TABLETS | 16 | 0.0060 |
| 5 | COLCHICINE | 123 | 0.0059 |
| 6 | IBUPROFEN AND DIPHENHYDRAMINE CITRATE | 86 | 0.0041 |
| 7 | SULFASALAZINE | 196 | 0.0033 |
| 8 | DICLOFENAC POTASSIUM | 16 | 0.0033 |
| 9 | RISEDRONATE SODIUM | 76 | 0.0032 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 206 |
| 1 | Aminosalicylate [EPC] | 196 |
| 2 | Folate Analog Metabolic Inhibitor [EPC] | 193 |
| 3 | Antirheumatic Agent [EPC] | 192 |
| 4 | Selective T Cell Costimulation Modulator [EPC] | 189 |
| 5 | Interleukin-6 Receptor Antagonist [EPC] | 188 |
| 6 | CD20-directed Cytolytic Antibody [EPC] | 179 |
| 7 | Nonsteroidal Anti-inflammatory Drug [EPC] | 149 |
| 8 | Corticosteroid [EPC] | 144 |
| 9 | Vitamin B12 [EPC] | 131 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Alkaloid [EPC] | 123 | 0.0059 |
| 1 | Standardized Chemical Allergen [EPC] | 43 | 0.0035 |
| 2 | Antirheumatic Agent [EPC] | 192 | 0.0023 |
| 3 | Interleukin-6 Receptor Antagonist [EPC] | 188 | 0.0021 |
| 4 | Aminosalicylate [EPC] | 196 | 0.0021 |
| 5 | Selective T Cell Costimulation Modulator [EPC] | 189 | 0.0019 |
| 6 | Interleukin-12 Antagonist [EPC] | 123 | 0.0018 |
| 7 | Interleukin-23 Antagonist [EPC] | 123 | 0.0013 |
| 8 | Calcineurin Inhibitor Immunosuppressant [EPC] | 85 | 0.0011 |
| 9 | CD20-directed Cytolytic Antibody [EPC] | 179 | 0.0009 |